Based on recent data, Rocket Pharmaceuticals, Inc. (RCKT) shows an Average True Range (ATR) of 0.24 and an Enterprise Value of 2.11B. Its average trading volume over the past 3 months is 2.38M, indicating liquidity. These fundamental metrics provide insight into RCKT's underlying financial health and market activity.
| ATR | 0.24 |
| Enterprise Value | 2.11B |
| Avg Vol (3 Months) | 2.38M |
| Avg Vol (10 Days) | 3.97M |
Rocket Pharmaceuticals, Inc. (RCKT) technical indicators as of March 12, 2026: the SMA 20 is 27.53%, SMA 50 at 26.93%, and SMA 200 at 31.27%. The RSI 14 value is 78.6, suggesting its current momentum. These technical analysis signals help assess RCKT's price trends and potential future movements.
| SMA 20 | 27.53% |
| SMA 50 | 26.93% |
| SMA 200 | 31.27% |
| RSI 14 | 78.6 |
Rocket Pharmaceuticals, Inc. (RCKT) stock performance overview as of March 12, 2026: The 52-week high is $8.89 (currently -53.98% below), and the 52-week low is $2.19 (currently 106.85% above). Over the past year, RCKT's performance is -64.35%, compared to the S&P 500's 18.53% change.
| 52-Week High | 8.89 |
| 52-Week High Chg | -53.98% |
| 52-Week Low | 2.19 |
| 52-Week Low Chg | +106.85% |
| S&P 500 52-Week Chg | 18.53% |
According to market data, Rocket Pharmaceuticals, Inc. (RCKT) stock's recent performance metrics show that over the last month, RCKT is 11.31%, with a Year-to-Date (YTD) performance of 3.7%. Over the past year, the stock has seen a -64.35% change. These figures summarize RCKT's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 5.45 | 5.45 | 5.45 | 5.45 | 8.89 | 5.45 |
| Low | 4.16 | 3.07 | 3 | 2.81 | 2.19 | 3 |
| Performance | +1.11% | +11.31% | -1.89% | +16.29% | -64.35% | +3.70% |
According to current financial data, RCKT stock's P/E (TTM) ratio is -2.44, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for RCKT, including P/S (N/A), P/B (1.96), and P/FCF (-2.79), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RCKT | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.44 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 1.96 | 4.26 | 5.23 | 4.72 |
| P/FCF (TTM) | -2.79 | -9.85 | -248.57 | 32.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep